Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP, Operations | July 27, 2012 | July 31, 2012 |
| Stevanato Group S.p.A.STVN · Entity 3826 | Director | March 18, 2026 | March 18, 2026 |
| XBiotech Inc.XBIT · Entity 7044 | Director | June 19, 2017 | June 23, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date July 27, 2012 · Filed July 31, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,608 |
Reported balance
After 2012-07-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-07-27 · Exercise / conversion · Acquired 42,109 · Balance 115,608 |
| Common StockSEC Table I · non-derivative | Direct | 157,510 |
Reported balance
After 2012-07-27 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-07-27 · Exercise / conversion · Acquired 41,902 · Balance 157,510 |
| Common StockSEC Table I · non-derivative | Direct | 187,510 |
Reported balance
After 2012-07-27 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2012-07-27 · Exercise / conversion · Acquired 30,000 · Balance 187,510 |
| Common StockSEC Table I · non-derivative | Direct | 271,510 |
Reported balance
After 2012-07-27 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2012-07-27 · Exercise / conversion · Acquired 84,000 · Balance 271,510 |
| Common StockSEC Table I · non-derivative | Direct | 334,510 |
Reported balance
After 2012-07-27 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2012-07-27 · Exercise / conversion · Acquired 63,000 · Balance 334,510 |
| Common StockSEC Table I · non-derivative | Direct | 376,510 |
Reported balance
After 2012-07-27 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2012-07-27 · Exercise / conversion · Acquired 42,000 · Balance 376,510 |
| Common StockSEC Table I · non-derivative | Direct | 73,499 |
Reported balance
After 2012-07-27 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2012-07-27 · Gift · Disposed 303,011 · Balance 73,499 F1: These shares are being transferred to the reporting person's Family Trust. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 363,639 |
Reported balance
After 2012-07-27 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2012-07-27 · Gift · Acquired 303,011 · Balance 363,639 F1: These shares are being transferred to the reporting person's Family Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 60,628 |
Reported balance
After 2012-07-27 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2012-07-27 · Sale · Disposed 303,011 · Balance 60,628 F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 48,491 |
Reported balance
After 2012-07-30 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2012-07-30 · Sale · Disposed 12,137 · Balance 48,491 F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.88 · Expires 2013-04-03 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-07-27 · Exercise / conversion · Disposed 42,109 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-07-27 · Exercise / conversion · Disposed 41,902 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.79 · Expires 2014-10-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-07-27 · Exercise / conversion · Disposed 30,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.13 · Expires 2015-04-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2012-07-27 · Exercise / conversion · Disposed 84,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.44 · Expires 2016-04-28 | Direct | 21,000 |
Reported balance
After 2012-07-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2012-07-27 · Exercise / conversion · Disposed 63,000 · Balance 21,000 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.43 · Expires 2020-04-26 | Direct | 42,000 |
Reported balance
After 2012-07-27 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2012-07-27 · Exercise / conversion · Disposed 42,000 · Balance 42,000 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are being transferred to the reporting person's Family Trust.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
Stevanato Group S.p.A.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectSecurities owned by you as trustee By Self as Co-Trustee for Self and Spouse | 119,700 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 119,700 |
XBiotech Inc.
Report date June 19, 2017 · Filed June 23, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2027-06-19 | Direct | 50,000 |
Reported balance
After 2017-06-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-19 · Exercise / conversion · Acquired 50,000 · Balance 50,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,026 | $56.23 | $170,151.98 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 12 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,379 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,200 | $56.22 | $123,684.00 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 11 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,405 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $56.21 | $11,242.00 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 10 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,605 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,584 | $56.20 | $89,020.80 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 9 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,805 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 301 | $56.19 | $16,913.19 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 8 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,389 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,701 | $56.16 | $95,528.16 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,132 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,121 | $56.15 | $62,944.15 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,833 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,612 | $56.14 | $146,637.68 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,954 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5 | $56.13 | $280.65 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,566 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,607 | $56.11 | $90,168.77 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,571 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,822 | $56.10 | $270,514.20 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,178 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 40,000 | $38.36 | $1,534,400.00 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · derivative · entry 14 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,393 Underlying: Common Stock · 40,000 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,442 | $56.17 | $193,337.14 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 12 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,558 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $56.45 | $11,290.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 11 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 3,600 | $56.44 | $203,184.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 10 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,200 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 300 | $56.43 | $16,929.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 9 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,800 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,200 | $56.42 | $124,124.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 8 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,100 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $56.33 | $5,633.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 130 | $56.32 | $7,321.86 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 880 | $56.31 | $49,552.89 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,530 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,748 | $56.31 | $154,739.88 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,410 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $56.29 | $11,258.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,158 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,000 | $56.28 | $56,280.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,358 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:38 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 400 | $56.27 | $22,508.00 |
DisclosureSEC source: 0001181431-08-058427 · rrd221659.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,358 Read SEC document |
| May 12, 2008 Filed May 14, 2008 20:42 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 22,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-031295 · rrd206768.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 57,488 F1 · kind: These shares are transferred tothe reporting person's Family Trust. Read SEC document |
| May 12, 2008 Filed May 14, 2008 20:42 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 18,067 | $41.86 | $756,284.62 |
DisclosureSEC source: 0001181431-08-031295 · rrd206768.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Read SEC document |
| May 12, 2008 Filed May 14, 2008 20:42 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 33,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-031295 · rrd206768.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,067 F1 · kind: These shares are transferred tothe reporting person's Family Trust. Read SEC document |
| May 07, 2008 Filed May 9, 2008 21:27 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 40,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-030265 · rrd206073.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,438 Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:11 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO Right to Buy) · Derivative | 84,000 | $42.13 Strike: $42.13 | $3,538,920.00 |
DisclosureSEC source: 0001181431-08-028020 · rrd204703.xml · derivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2015-04-29 F2 · derivative.exercise_date: This option is exercisable in four equal annual installments of 25% each commencing April 29, 2009. Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:11 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-028020 · rrd204703.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest in four equal annual installments of 25% each commencing on April 29, 2009. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the executive officer. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 17:03 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 30,000 | $56.79 Strike: $56.79 | $1,703,700.00 |
DisclosureSEC source: 0001181431-07-064923 · rrd176485.xml · derivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2014-10-29 F1 · derivative.exercise_date: This option is exercisable in four equal annual installments of 7,500 each commencing October 29, 2008. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · derivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,190 Underlying: Common Stock · 30,000 shares Expires 2006-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $62.08 | $1,862,463.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530 F1 · balance_after: (FB 3.07.05) Does not include 6,901 shares indirectly held by the family trust. Read SEC document |
| March 07, 2005 Filed Mar 8, 2005 18:17 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $39.03 | $1,170,939.00 |
DisclosureSEC source: 0001181431-05-015246 · rrd71753.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 3.07.05) Does not include 6,901 shares indirectly held by the family trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · derivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,190 Underlying: Common Stock · 35,000 shares Expires 2006-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 39,000 | $61.95 | $2,415,855.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130 F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 4,000 | $30.44 | $121,750.00 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| January 31, 2005 Filed Feb 1, 2005 17:36 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 35,000 | $39.03 | $1,366,095.50 |
DisclosureSEC source: 0001181431-05-005944 · rrd66713.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (FB 01/05) The reporting person no longer has a reportable beneficial interest in 550 shares of Amgen Inc. common stock owned by his daughter and 550 shares of Amgen Inc. common stock owned by his son and included in the reporting person's prior ownership reports. In addition, does not include 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:57 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 170 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-037403 · rrd49054.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130 F1 · balance_after: (FB 7.27.04) Does not include (i) 550 shares held indirectly by reporting person's son, (ii) 550 shares held indirectly by reporting person's daughter, and (iii) 6,901 shares held indirectly by reporting person's trust. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:39 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015977 · rrd36780.xml · derivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:39 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015977 · rrd36780.xml · derivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| February 02, 2004 Filed Feb 3, 2004 01:10 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 46 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-005764 · rrd31211.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · balance_after: The amount of the Company's Common Stock beneficially owned following this transaction and held directly by the reporting person has been adjusted to reflect an acquisition of the Company's Common Stock under the 423(b) Plan in a transaction exempt pursuant to Rule 16a-3(f)(l)(k)(B). Does not include (i) 550 shares held as indirect ownership by the reporting person's son, (ii) 550 shares held as indirect ownership by the reporting person's daughter, and (iii) 6,901 shares held as indirect ownership by the Family Trust. Read SEC document |
| October 08, 2003 Filed Oct 9, 2003 23:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-026327 · rrd20158.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 6,901 Read SEC document |
| October 08, 2003 Filed Oct 9, 2003 23:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 2,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-026327 · rrd20158.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 7,301 F1 · shares: (FB 10/6/03) These shares were previously reported as directly beneficially owned and were transferred by the reporting person to the Family Trust. Read SEC document |
| October 08, 2003 Filed Oct 9, 2003 23:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-026327 · rrd20158.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 550 Read SEC document |
| October 08, 2003 Filed Oct 9, 2003 23:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-026327 · rrd20158.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 550 Read SEC document |
| October 08, 2003 Filed Oct 9, 2003 23:27 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 2,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-026327 · rrd20158.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840 F1 · shares: (FB 10/6/03) These shares were previously reported as directly beneficially owned and were transferred by the reporting person to the Family Trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 16:38 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $39.03 | $0.00 |
DisclosureSEC source: 0001181431-03-016644 · rrd14804.xml · derivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · Senior V.P. Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,190 Underlying: Common Stock · 12,000 shares Expires 2006-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: (FB-04/99-NQSO) The option becomes exercisable for 37,438 shares on April 12, 2000, April 12, 2001, April 12, 2002, April 12, 2003 and April 12, 2004, respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.